Literature DB >> 7227851

Effect of prednisolone on prostaglandin synthesis by rectal mucosa in ulcerative colitis: investigation by laminar flow bioassay and radioimmunoassay.

C J Hawkey, S C Truelove.   

Abstract

The effect of two concentrations of prednisolone on synthesis of prostaglandin E2 (PGE2) by 40 rectal biopsies in organ culture was investigated using both laminar flow bioassay and radioimmunoassay (RIA). Prednisolone (concentration 8.33 x 10(-7)M) reduced mean synthesis of PGE2 to 36.4% of control values (measured by bioassay) or 26.2% of control values (measured by RIA). With prednisolone (concentration 5.66 X 10(-4) M) synthesis of PGE2 was 7.7% of control values (RIA). The two concentrations are similar respectively to those achieved in plasma after oral prednisolone and delivered topically by prednisolone enemata. Inhibition of PG synthesis may thus explain prednisolone's anti-inflammatory action in the treatment of ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7227851      PMCID: PMC1419508          DOI: 10.1136/gut.22.3.190

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  18 in total

1.  Biopsy studies in ulcerative colitis.

Authors:  S C TRUELOVE; W C RICHARDS
Journal:  Br Med J       Date:  1956-06-09

2.  A laminar flow superfusion technique with much increased sensitivity for the detection of smooth muscle-stimulating substances.

Authors:  S H Ferreira; F De Souza Costa
Journal:  Eur J Pharmacol       Date:  1976-10       Impact factor: 4.432

3.  Assay of prostaglandin-like substances in faeces and their measurement in ulcerative colitis.

Authors:  S R Gould
Journal:  Prostaglandins       Date:  1976-03

4.  Organ culture of human rectal mucosa.

Authors:  G L Eastwood; J S Trier
Journal:  Gastroenterology       Date:  1973-03       Impact factor: 22.682

5.  Increased prostaglandin production in ulcerative colitis.

Authors:  S R Gould; A R Brash; M E Conolly
Journal:  Lancet       Date:  1977-07-09       Impact factor: 79.321

6.  Extraction of prostaglandins from human blood.

Authors:  W G Unger; I F Stamford; A Bennett
Journal:  Nature       Date:  1971-10-01       Impact factor: 49.962

7.  Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine.

Authors:  P Sharon; M Ligumsky; D Rachmilewitz; U Zor
Journal:  Gastroenterology       Date:  1978-10       Impact factor: 22.682

8.  Radioimmunoassay of prostaglandins Falpha, E1 and E2 in human plasma.

Authors:  F Dray; B Charbonnel; J Maclouf
Journal:  Eur J Clin Invest       Date:  1975-07-29       Impact factor: 4.686

9.  Phospholipase A2 activity of guinea-pig isolated perfused lungs: stimulation, and inhibition by anti-inflammatory steroids.

Authors:  G J Blackwell; R J Flower; F P Nijkamp; J R Vane
Journal:  Br J Pharmacol       Date:  1978-01       Impact factor: 8.739

10.  An experiment to determine the active therapeutic moiety of sulphasalazine.

Authors:  A K Azad Khan; J Piris; S C Truelove
Journal:  Lancet       Date:  1977-10-29       Impact factor: 79.321

View more
  21 in total

Review 1.  Inflammatory intermediaries in inflammatory bowel disease.

Authors:  K Lauritsen; L S Laursen; K Bukhave; J Rask-Madsen
Journal:  Int J Colorectal Dis       Date:  1989       Impact factor: 2.571

Review 2.  Immunosuppressive drugs in inflammatory bowel disease. A review of their mechanisms of efficacy and place in therapy.

Authors:  A B Hawthorne; C J Hawkey
Journal:  Drugs       Date:  1989-08       Impact factor: 9.546

Review 3.  Prostaglandins and ulcerative colitis.

Authors:  D S Rampton; C J Hawkey
Journal:  Gut       Date:  1984-12       Impact factor: 23.059

4.  Proceedings of the Fiftieth Anniversary Meeting of the British Pharmacological Society, University of Oxford, 16-18 September 1981. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1981-12       Impact factor: 8.739

Review 5.  Toward optimal use of corticosteroids in ulcerative colitis and Crohn's disease.

Authors:  J E Lennard-Jones
Journal:  Gut       Date:  1983-03       Impact factor: 23.059

Review 6.  Organ culture of gastrointestinal mucosa--a technique for the study of the human gastrointestinal tract.

Authors:  P D Howdle
Journal:  Postgrad Med J       Date:  1984-10       Impact factor: 2.401

7.  In vitro model for the assessment of luminal factors on rectal mucosa.

Authors:  A Allan; D P Jewell
Journal:  Gut       Date:  1983-09       Impact factor: 23.059

8.  5-Aminosalicylic acid is a potent inhibitor of interleukin 1 beta production in organ culture of colonic biopsy specimens from patients with inflammatory bowel disease.

Authors:  Y R Mahida; C E Lamming; A Gallagher; A B Hawthorne; C J Hawkey
Journal:  Gut       Date:  1991-01       Impact factor: 23.059

9.  In vivo rectal inflammatory mediator changes with radiotherapy to the pelvis.

Authors:  A T Cole; K Slater; M Sokal; C J Hawkey
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

10.  Biosynthesis of lipoxygenase and cyclo-oxygenase products from [14C]-arachidonic acid by human colonic mucosa.

Authors:  N K Boughton-Smith; C J Hawkey; B J Whittle
Journal:  Gut       Date:  1983-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.